BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 15171256)

  • 1. Regulation of NF-kappaB action by reversible acetylation.
    Greene WC; Chen LF
    Novartis Found Symp; 2004; 259():208-17; discussion 218-25. PubMed ID: 15171256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation.
    Chen LF; Greene WC
    J Mol Med (Berl); 2003 Sep; 81(9):549-57. PubMed ID: 12920522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing acetylation of NF-kappaB.
    Chen LF; Greene WC
    Methods; 2005 Aug; 36(4):368-75. PubMed ID: 16111893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of nuclear NF-kappaB action regulated by reversible acetylation.
    Chen Lf ; Fischle W; Verdin E; Greene WC
    Science; 2001 Aug; 293(5535):1653-7. PubMed ID: 11533489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.
    Chen LF; Mu Y; Greene WC
    EMBO J; 2002 Dec; 21(23):6539-48. PubMed ID: 12456660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J; Colburn NH
    Mol Cancer Res; 2005 Feb; 3(2):100-9. PubMed ID: 15755876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression.
    Rahman I; Marwick J; Kirkham P
    Biochem Pharmacol; 2004 Sep; 68(6):1255-67. PubMed ID: 15313424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pervasive role of histone acetyltransferases and deacetylases in an NF-kappaB-signaling code.
    Calao M; Burny A; Quivy V; Dekoninck A; Van Lint C
    Trends Biochem Sci; 2008 Jul; 33(7):339-49. PubMed ID: 18585916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
    Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
    Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells.
    Ho WC; Dickson KM; Barker PA
    Cancer Res; 2005 May; 65(10):4273-81. PubMed ID: 15899819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.
    Grégoire S; Xiao L; Nie J; Zhang X; Xu M; Li J; Wong J; Seto E; Yang XJ
    Mol Cell Biol; 2007 Feb; 27(4):1280-95. PubMed ID: 17158926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation of SRC-1 and p300 with NF-kappaB and CREB in angiotensin II-induced IL-6 expression in vascular smooth muscle cells.
    Sahar S; Reddy MA; Wong C; Meng L; Wang M; Natarajan R
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1528-34. PubMed ID: 17495236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of VCAM-1 expression by tumor necrosis factor-alpha in human tracheal smooth muscle cells: involvement of MAPKs, NF-kappaB, p300, and histone acetylation.
    Lee CW; Lin WN; Lin CC; Luo SF; Wang JS; Pouyssegur J; Yang CM
    J Cell Physiol; 2006 Apr; 207(1):174-86. PubMed ID: 16288471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo binding of NF-kappaB to the IkappaBbeta promoter is insufficient for transcriptional activation.
    Griffin BD; Moynagh PN
    Biochem J; 2006 Nov; 400(1):115-25. PubMed ID: 16792530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of histone acetyltransferases and deacetylases in gene regulation.
    Kuo MH; Allis CD
    Bioessays; 1998 Aug; 20(8):615-26. PubMed ID: 9780836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated p53 induces NF-kappaB DNA binding but suppresses its transcriptional activation.
    Kawauchi K; Araki K; Tobiume K; Tanaka N
    Biochem Biophys Res Commun; 2008 Jul; 372(1):137-41. PubMed ID: 18477470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of NF-kappaB acetylation and its transcriptional activity by Daxx.
    Park J; Lee JH; La M; Jang MJ; Chae GW; Kim SB; Tak H; Jung Y; Byun B; Ahn JK; Joe CO
    J Mol Biol; 2007 Apr; 368(2):388-97. PubMed ID: 17362989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYBBP1a is a novel repressor of NF-kappaB.
    Owen HR; Elser M; Cheung E; Gersbach M; Kraus WL; Hottiger MO
    J Mol Biol; 2007 Feb; 366(3):725-36. PubMed ID: 17196614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of post-translational modifications of proteins on the inflammatory process.
    Ito K
    Biochem Soc Trans; 2007 Apr; 35(Pt 2):281-3. PubMed ID: 17371260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.